Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Plasma Kinetics of Tablet and Liquid Formulations of 6-mercaptopurine in Childhood Acute Lymphoblastic Leukemia.

NCT01906671 is registered in ClinicalTrials.gov with Kjeld Schmiegelow as lead sponsor.

NCT NCT01906671
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01906671 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Plasma Kinetics of Tablet and Liquid Formulations of 6-mercaptopurine in Childhood Acute Lymphoblastic Leukemia.
Lead sponsor
Kjeld Schmiegelow
Phase
Phase 4
Overall status
Unknown status
Start date
June 30, 2013
Completion date
November 30, 2018
Enrollment
16 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

6-mercaptopurine therapy, acute lymphoblastic leukemia